TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive Practice of Oncology Must Incorporate Clinical Research, NCI Director Tells ASCO May 30, 1997